| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/01/2006 | CN1726922A Usage of stigmastane-3,5,6-alcohol and derivative for preparing antiviral remedy, and new stigmastane-3,5,6-derivative of tri-alcohol |
| 02/01/2006 | CN1726919A Oral disintegration tablet of cefixime |
| 02/01/2006 | CN1726917A Ganciclovir lactated ringer solution and preparation method |
| 02/01/2006 | CN1726913A Powder and injection preparation of ciprofloxacin hydrochloride, and preparing method |
| 02/01/2006 | CN1726908A Oral emulsion combination of 'Chuanhuning' |
| 02/01/2006 | CN1726885A Bracket for eluting TINI based medication and preparation method |
| 02/01/2006 | CN1239511C Novel pyrazine derivatives or salts thereof, containing the derives or the salts and intermediates for the preparation of both |
| 02/01/2006 | CN1239496C Respiratory syncytial virus replication inhibitors |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239472C HIV integrase inhibitors |
| 02/01/2006 | CN1239188C Use of Chinese medicine composition in preparing medicine for anti SARS virus |
| 02/01/2006 | CN1239178C Method for preparing qingkailing granules |
| 02/01/2006 | CN1239169C Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 02/01/2006 | CN1239149C Pharmaceutical formulation having masked taste and method for production thereof |
| 01/31/2006 | US6992190 Hydroxamic acid derivatives as antibacterials |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992176 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 01/31/2006 | US6992098 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |
| 01/31/2006 | US6992072 comprises pyrimidine-based nucleosides; highly active anti-retroviral therapy; treating lipoatrophy, dyslipidemia, and insulin resistance resulting from administration of nucleoside reverse transcriptase inhibitors |
| 01/31/2006 | US6991929 Hepatitis A vaccines |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/31/2006 | US6991800 containing an echinocandin antifungal compound and an aqueous solvent, wherein the formulation includes about 20% w/v ethanol; extended shelf life, improved solubility |
| 01/31/2006 | US6991786 Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics |
| 01/31/2006 | US6991785 Administering by tissue absorption |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/31/2006 | CA2346447C Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
| 01/26/2006 | WO2006009764A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020130 Spraying a cefuroxime axetil solution via an atomizer into a stirred reactor containing an antisolvent to precipitate and crystallize the cefuroxime axetil into a slurry via antisolvent recrystallization; filtering and drying to obtain amorphous cefuroxime axetil powder; particle size of 20nm-30mu m. |
| 01/26/2006 | US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019246 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060019239 enhancing the immunogenicity of a vaccine against Bacillus anthracis by administering an oligodeoxynucleotide with a vaccine against Bacillus anthracis; Anthrax Vaccine Adsorbed (AVA) vaccine |
| 01/26/2006 | US20060018984 Intravaginal washing agent |
| 01/26/2006 | US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018876 Treatment of diseases caused by viral infection |
| 01/26/2006 | US20060018847 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 01/26/2006 | DE102004032711A1 Substituierte Hydroxyacetophenonderivate Substituted hydroxyacetophenone |
| 01/26/2006 | CA2581068A1 Treatment of tumours |
| 01/26/2006 | CA2574477A1 Alpha-defensins as anthrax immunotherapeutics |
| 01/26/2006 | CA2574464A1 Substituted quinolones |
| 01/26/2006 | CA2574354A1 Imidazole and thiazole derivatives as antiviral agents |
| 01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
| 01/26/2006 | CA2570471A1 Use of apo2l receptor agonists and nk cells or nk cell activators |
| 01/25/2006 | EP1619254A1 Transfer of mRNA using polycationic compounds |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619207A2 HLA-A2.1 binding peptides derived from HCV and their uses |
| 01/25/2006 | EP1619198A1 Amorphous cefuroxime axetil and preparation process therefore |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1618889A2 Influenza Vaccine |
| 01/25/2006 | EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles |
| 01/25/2006 | EP1618877A1 Dilution-type sterilizer composition |
| 01/25/2006 | EP1618874A2 Prevention of hiv-1 infection by inhibition of rho-mediated reorganisation and/or content alteration of cell membrane raft domains |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618120A2 Novel ketolide derivatives |
| 01/25/2006 | EP1618119A2 Pyridyl substituted ketolide antibiotics |
| 01/25/2006 | EP1618106A2 Carbacephem -lactam antibiotics |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1617866A2 Modified live vaccines comprising bhv-1 (ibr) and/or bvdv for pregnant and nursing cattles |
| 01/25/2006 | EP1617858A2 Use of active ingredients for preventing or treating viral illnesses, and test system for discovering such active ingredients |
| 01/25/2006 | EP1617824A1 Pharmaceutical composition containing ribavirin as active substance and method of manufacturing thereof |
| 01/25/2006 | EP1617731A2 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 01/25/2006 | EP1392241A4 System for osmotic delivery of pharmaceutically active agents |
| 01/25/2006 | EP1372627B1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/25/2006 | EP1151121B1 Recombined porcine adenovirus based viral vaccines and vectors |
| 01/25/2006 | EP1115408B1 Oxihumic acid and its use in the treatment of various conditions |
| 01/25/2006 | EP1062325B1 Purification of virus preparations |
| 01/25/2006 | CN1726287A Method of distinguishing drug-resistance of hepatitis b virus |
| 01/25/2006 | CN1726222A Novel semisynthetic macrolide antibiotics of the azalide series |
| 01/25/2006 | CN1726199A Novel 2,4-diamino-1,3,5-triazine derivative |
| 01/25/2006 | CN1726047A Vaccine comprising an antigen conjugated to low valency anti-CD40 or anti-CD28 antibodies |
| 01/25/2006 | CN1726041A Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) with an inhibitor of cytochrome p450, such as protease inhibitors |
| 01/25/2006 | CN1726018A Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents |
| 01/25/2006 | CN1724570A Anthrax toxin acceptor ATR-Fc fusion protein |
| 01/25/2006 | CN1724566A Antibacterial, anti indextoxin allesteric peptide molecular and its synthesis method |
| 01/25/2006 | CN1724560A Antigen simulating epipeptide of C type para chicken blood phili bacillus and its use |
| 01/25/2006 | CN1724559A Antigen simulating epipeptide of A type parachicken blood phili bacillus and its use |
| 01/25/2006 | CN1724549A Nucleoside phosphonate compound |
| 01/25/2006 | CN1724533A Method of extracting deydrokaividing and solubilizing injection agent from rock gold thread total alkaloid |
| 01/25/2006 | CN1724527A Application of fraxiketone as medicine for treating liver disease |
| 01/25/2006 | CN1724071A Novel use of cell wall skeleton of red nocar-ray-fungus for treating liver diseases |
| 01/25/2006 | CN1724069A Method for preparing vaccine of fowl infectious coryza |